Zacks Investment Research cut shares of Maximus, Inc. (NYSE:MMS) from a buy rating to a hold rating in a report published on Tuesday morning.
According to Zacks, “MAXIMUS, Inc. is an extremely dynamic and complex organization that offers government and industry a range of unique services, products, and solutions. The diverse services and products that MAXIMUS offers may be categorized into three groups: Government Program Management and Operations, Consulting, and Systems. Government Program Management and Operations focuses on having a measurable impact on the lives of the citizens we help government serve. The insights of MAXIMUS Consulting, and the technological innovations advanced through Systems, help government gain program efficiencies and pursue improvements that in turn benefit citizens. “
Several other equities analysts also recently weighed in on MMS. Maxim Group set a $66.00 target price on Maximus and gave the company a hold rating in a research report on Thursday, August 3rd. BidaskClub downgraded Maximus from a hold rating to a sell rating in a research report on Monday, July 24th. Robert W. Baird reissued a hold rating and set a $64.00 target price on shares of Maximus in a research report on Friday, September 1st. Finally, Canaccord Genuity downgraded Maximus from a buy rating to a hold rating and set a $62.00 target price on the stock. in a research report on Tuesday, July 4th. One investment analyst has rated the stock with a sell rating and nine have given a hold rating to the company’s stock. The stock currently has an average rating of Hold and an average target price of $63.14.
Shares of Maximus (NYSE MMS) traded up 0.09% on Tuesday, reaching $65.33. 61,550 shares of the company’s stock were exchanged. The firm has a market cap of $4.24 billion, a PE ratio of 20.94 and a beta of 1.36. The company has a 50 day moving average price of $63.07 and a 200 day moving average price of $61.94. Maximus has a one year low of $43.69 and a one year high of $66.38.
Maximus (NYSE:MMS) last released its earnings results on Thursday, August 3rd. The health services provider reported $0.79 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.76 by $0.03. The firm had revenue of $600.40 million for the quarter, compared to the consensus estimate of $614.12 million. Maximus had a return on equity of 25.08% and a net margin of 8.43%. The company’s revenue for the quarter was down 2.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.79 EPS. Analysts expect that Maximus will post $3.13 EPS for the current fiscal year.
WARNING: “Zacks Investment Research Lowers Maximus, Inc. (MMS) to Hold” was posted by Ticker Report and is owned by of Ticker Report. If you are viewing this story on another website, it was copied illegally and republished in violation of United States & international copyright and trademark law. The correct version of this story can be accessed at https://www.tickerreport.com/banking-finance/2957637/zacks-investment-research-lowers-maximus-inc-mms-to-hold.html.
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, November 30th. Shareholders of record on Wednesday, November 15th will be given a $0.045 dividend. This represents a $0.18 annualized dividend and a yield of 0.28%. The ex-dividend date is Tuesday, November 14th. Maximus’s dividend payout ratio (DPR) is presently 5.73%.
In other Maximus news, CEO Richard A. Montoni sold 29,203 shares of the company’s stock in a transaction on Thursday, August 17th. The stock was sold at an average price of $60.38, for a total value of $1,763,277.14. Following the transaction, the chief executive officer now owns 549,215 shares of the company’s stock, valued at approximately $33,161,601.70. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, General Counsel David Francis sold 2,000 shares of the company’s stock in a transaction on Friday, August 18th. The shares were sold at an average price of $58.89, for a total value of $117,780.00. Following the completion of the transaction, the general counsel now directly owns 13,716 shares in the company, valued at approximately $807,735.24. The disclosure for this sale can be found here. Insiders sold a total of 151,403 shares of company stock worth $9,354,041 in the last ninety days. 3.10% of the stock is currently owned by corporate insiders.
A number of institutional investors have recently made changes to their positions in the business. BlackRock Inc. grew its position in Maximus by 22,491.0% in the 1st quarter. BlackRock Inc. now owns 6,503,511 shares of the health services provider’s stock valued at $404,518,000 after acquiring an additional 6,474,723 shares during the last quarter. Vanguard Group Inc. grew its position in Maximus by 2.4% in the 2nd quarter. Vanguard Group Inc. now owns 5,669,026 shares of the health services provider’s stock valued at $355,052,000 after acquiring an additional 130,839 shares during the last quarter. FMR LLC grew its position in Maximus by 10.4% in the 2nd quarter. FMR LLC now owns 4,658,584 shares of the health services provider’s stock valued at $291,767,000 after acquiring an additional 438,025 shares during the last quarter. Victory Capital Management Inc. grew its position in Maximus by 8.6% in the 2nd quarter. Victory Capital Management Inc. now owns 3,100,903 shares of the health services provider’s stock valued at $194,210,000 after acquiring an additional 244,823 shares during the last quarter. Finally, Janus Henderson Group PLC lifted its holdings in shares of Maximus by 718.8% in the 2nd quarter. Janus Henderson Group PLC now owns 2,211,638 shares of the health services provider’s stock worth $138,515,000 after buying an additional 1,941,521 shares during the period. 97.23% of the stock is currently owned by institutional investors.
Maximus Company Profile
MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related companies with MarketBeat.com's FREE daily email newsletter.